Okubo, Reiko
Ohigashi, Tomohiro
Kondo, Masahide
Tsunoda, Ryoya
Kai, Hirayasu
Saito, Chie
Hoshino, Junichi
Okada, Hirokazu
Narita, Ichiei
Maruyama, Shoichi
Wada, Takashi
Yamagata, Kunihiro
Article History
Received: 6 September 2024
Accepted: 5 November 2024
First Online: 19 November 2024
Declarations
:
: The study protocol was approved by the Tsukuba Ethical Committee (approval number: H27-199). Informed consent was obtained from all participants included in this study. This study was also approved by the steering committee of the Reach-J CKD cohort study and was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: All authors had conflicts of interest related to Mitsubishi Tanabe Pharma Corporation.